• CNS Pharmaceuticals is a clinical stage biotechnology company focused on the development of novel treatments for brain tumors
• The company’s lead product candidate, Berubicin, is a novel anthracycline that is designed to cross the blood-brain barrier
• The blood-brain barrier ordinarily hinders the vascular delivery of therapeutic substances to brain tumors
• By crossing this protective barrier, Berubicin holds promise for the thousands of adult Americans diagnosed with malignant central nervous system cancers annually

This year, about 25,050 adults (14,170 men and 10,880 women) will be diagnosed with malignant central nervous system (“CNS”) tumors – cancerous tumors that start in the spinal cord or brain. The figure represents an increase from an estimated 24,530 cases documented last year. Of these statistics, the American Society of Clinical Oncology (“ASCO”) notes that brain tumors account for 85-90% of all primary CNS tumors (https://ibn.fm/c9ThB). But despite this prevalence, the treatment of brain tumors has long been complicated by the brain’s internal workings. A healthy human brain has a mechanism known as the blood-brain barrier that protects the active functions of the CNS and blocks toxins and microorganisms from passing through the highly picky semipermeable border. While this barrier promotes stability of the sensitive internal environment of the brain, it complicates the treatment of brain tumors. Most notably, it hinders the vascular delivery of various therapeutic substances, including anthracyclines, to the cancerous growths within the brain’s internal environment (https://ibn.fm/YZGPK). “[Anthracycline] is a classic drug that’s been around for 60 years. It’s the first line therapeutic for all sorts of difficult-to-treat cancers. But no one has been able to get a drug like this across the blood-brain barrier until our Founder modified the classic anthracycline molecule to be more effective in crossing the blood-brain barrier,” CNS Pharmaceuticals (NASDAQ: CNSP) President & CEO John Climaco told Proactive last fall (https://ibn.fm/em55b). Following the modifications, now woven into the company’s lead product candidate, Berubicin – a novel anthracycline designed to concentrate in tumor tissue within the brain – CNS Pharmaceuticals is targeting the treatment of glioblastoma multiforme (“GBM”). GBM, also known as a grade IV astrocytoma, is the most malignant, aggressive, and common form of astrocytoma – a type of brain cancer – and is one of the most treatment-resistant cancers that form in the brain (https://ibn.fm/fed4R). Historically, a GBM diagnosis often led to a prognosis of months or less to live. But this narrative is changing, with research and clinicians’ work helping prolong patients’ lives. Founded in 2017, CNS Pharmaceuticals is leading the charge toward advancing research on the treatment for GBM as well as other primary and metastatic brain and CNS cancers. Last year, the company commenced a potentially pivotal clinical trial of Berubicin for the treatment of GBM, dosing its first patients in September (https://ibn.fm/cE5xu). The company expects to report an interim analysis of the trial when 30-50% of the planned subjects reach six months in-study, potentially in the first half of 2023. The adaptive, multicenter, open-label, randomized, and controlled study will involve about 243 adult patients with recurrent GBM after failure of standard first-line therapy. The subjects will be randomized in a 2:1 ratio to receive Berubicin or lomustine, a compound used in chemotherapy, to evaluate Overall Survival, the study’s primary endpoint. The study is expected to potentially build on the Phase 1 trial and pharmacokinetic study of Berubicin, whose results revealed that 44% of the patients showed clinical response of stable disease or better, with one patient demonstrating a lack of detectable cancer cells and two patients with partial tumor reduction of up to 80%. In a recent update, CNS Pharmaceuticals also celebrated the production of a new mesylate salt of its WP1244 drug technology, now known as WP1874, whose improved solubility may enhance its ability to be formulated for use in an IV infusion. WP1874 is believed to retain the potency and toxicity attributes of WP1244, which, in turn, was shown to be 500x more potent than daunorubicin in inhibiting tumor cell proliferation. Moving forward, CNS Pharmaceuticals expects to primarily focus its development efforts of the WP1244 portfolio on the newly minted WP1874. The company is also investigating the use of WP1244/WP1874 in treating other primary CNS cancers as well as brain metastases such as pancreatic, ovarian, and lymphoma (https://ibn.fm/CLVDb). For more information, visit the company’s website at www.CNSPharma.com. NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

• Recent study forecasts global mental health market to reach almost $538B by 2030
• One in five people in the United States deals with mental illness, including depression, anxiety, PTSD and more
• Cybin is moving three drug candidates forward, targeting major depressive, alcohol use and anxiety disorders

A recent market study reports that the global mental health market, which was valued at $383.31 billion in 2020, is estimated to reach $537.97 billion by 2030, growing at a compound annual growth rate of 3.5% from 2021 to 2030 (https://ibn.fm/J7hfJ). With three active drug programs targeting mental-health disorders, Cybin (NEO: CYBN) (NYSE American: CYBN) is establishing itself as a leader in revolutionizing mental health treatments. “Mental health problems are characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms,” the recent Allied Market Research report states. “Increase in prevalence of mental disorders, rise in geriatric population, and growth in awareness programs regarding mental health drive the market growth. Moreover, growing awareness about mental disorders through education and advocacy for more respect of human rights and less stigma drive the growth of the global mental health market.” Noting that one in five people in the United States suffers from mental illness, the report cites alcohol use disorders, bipolar disorder, depression, anxiety, post-traumatic stress disorder, substance abuse disorders, and eating disorders as some of the major categories in the mental-health space. The study reported that the depression segment dominates the market and is expected to continue this trend throughout the forecast period. “Factors such as genes as well as stress and brain chemistry lead to depression,” the report states. “According to the WHO, more than 264 million people of all ages suffered from depression in 2020. Depression is a leading cause of disability worldwide, and is a major contributor to the overall global burden of disease.” In its commitment to transform the mental health treatment landscape, Cybin is combining novel psychedelic molecules with controllable drug-delivery systems through its proprietary deuterated process, thus creating patent-protected, commercially scalable drug candidates. The company currently is moving three of these drug candidates forward: CYB003, CYB004 and CYB005 (https://ibn.fm/bqIt6). Cybin’s active drug programs target major depressive disorder (CYB003), alcohol use disorder (CYB003), anxiety disorders (CYB004) and neuroinflammation (CYB005).  The company recently announced that it commenced a company-sponsored feasibility study with its partner Kernel to evaluate Kernel’s quantitative neuroimaging technology, Kernel Flow(R). The Flow headset, which is equipped with hi-tech sensors, will be used to collect and quantify longitudinal brain activity before, during and after a psychedelic experience. Cybin also has 50 novel compounds developed with multiple patent filings across three patent families. In terms of investor interest, Cybin has raised $120 million to date to support its clinical trials and M&A strategy. In addition, the company is working with a network of world-class partners and internationally recognized scientists to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom and Ireland. The company is focused on progressing psychedelics to therapeutics by engineering proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens for mental health disorders. For more information, visit the company’s website at www.Cybin.com. NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

• Friendable has seen a positive month over month growth trend across Facebook, Instagram and Twitter (3.8%) that is almost four times the industry average
• The current metrics, as described by CEO Robert A. Rositano, Jr. are key indicators of the company’s market penetration and next stages of growth
• The Fan Pass Live April contest will give the top five ticket selling artists the opportunity to win free music distribution for an entire year

Friendable (OTC: FDBL), a mobile technology and marketing company, has announced the addition of social media platform TikTok to its social media engagement and marketing efforts. The decision comes as the company continues to see a positive month-over-month trend across other platforms – with an overall positive engagement rate of 3.8% on Facebook, Twitter, and Instagram (https://ibn.fm/Rq03E). The industry average for social engagement rate for media is only 1%. Friendable also reported an overall increase of 5.4% for March 2022 across the three platforms (before commencing TikTok campaigns). Robert A. Rositano, Jr., CEO of Friendable, explained that, as the company’s artist platform, business model and full 360 suite of services have become available, the team has been focusing its attention on extending reach, brand awareness, and partnerships, that provide more exposure to the company’s offerings. “In addition to being excited about the launch of TikTok to our digital campaigns, we have also achieved a 60.4% increase on Facebook page likes and increased our engagement rate by 7%, with the impression rate increasing by another 1.4%,” Rositano Jr. added. “Thank you to our team, our partners, and our shareholders, please stay tuned as we continue trending upward in what we believe are key indicators of our market penetration and preparation for next stages of growth.” Key Insights – March 2022 – Facebook, Instagram, and Twitter Total audience growth for the three platforms during March was up 6.1%, with the overall engagement rate increasing to 6.3%. Both Artist Republik and Fan Pass Live saw increases across social platforms: Artist Republik Facebook:

• Page Reach up 26%
• Post Engagement up 257%
• Page Likes up 70%

Instagram:

• Account Reach up 71.2%
• Account Engagement up 100%

Fan Pass Live Facebook:

• People Reach up 10%
• Page Likes up 34%

Instagram:

• Account Reach up 18.4%

In January 2022, Friendable completed the acquisition of Artist Republik and FeaturedX. Together with the already successful Fan Pass Live artist platform, the company has positioned itself as the first 360 artist suite in the industry – offering independent musicians the ability to manage their own music from start to finish. Artists have several opportunities to earn revenue, from merchandise to ticket sales and monthly subscription fees for fans to exclusive artist-only contests. Each month Friendable promotes an artist contest for those signed up on their platform. The contest is a way for artists to earn additional funds and increase their exposure. For April, the Fan Pass Live Instagram account, @fanpasslive, posted the newest contest – Stream to Win. The top five artists with the most ticket sales in April will win free unlimited music distribution for a year. It is easy to participate; join Fan Pass Live, set your ticket price, invite fans, and keep 100% of ticket sales! As a bonus, artists who promote three streams on Instagram and tag @fanpasslive can win a free Grow with Us Campaign ($10 value) to add listeners to Spotify and Soundcloud. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• Graphene face masks designed by Kronos remove 99.9% of bacteria, virus particles
• KNOS believes these are the highest filtration-efficiency numbers for any face masks in the market
• Kronos is focused on next-generation wellness consumer-electronics products and PPE solutions

Kronos Advanced Technologies (OTC: KNOS) is continuing its role as a leader in the world of advanced air filtration. The company offers N95 face masks made in the USA by a NIOSH-certified facility and Kronos-designed graphene face masks, an ideal addition to the company’s line of products designed to fight viruses and kill germs. “An N95 mask is a type of respirator that meets U.S. quality standards,” states the Mayo Clinic (https://ibn.fm/wI7kM). “An N95 offers the highest level of protection. It offers more protection than a medical mask does because it filters out both large and small particles when the wearer inhales. Nonsurgical N95s can be used by the general public.” According to Kronos CEO Michael Rubinov, “Our goal is to provide the best available protective face masks on the market for those in higher-exposure risk environments, with the best technology available. Our Kronos graphene technology achieves this not only as of the highest protection properties but also by completely reducing the number of viable bacteria and virus particles that are able to pass through the mask materials to zero” (https://ibn.fm/A1xB2). According to Kronos, its five-ply graphene face masks remove 99.9% of bacteria and virus particles compared to the common and far less efficacious ASTM level 3 mask. The company noted that ASTM level 3 is the FDA’s highest rating for medical and surgical face masks, and the Kronos face mask is the only five-ply graphene mask known to be manufactured in the United States. “With BFE and VFE levels over 99.9%, the company believes that these are the highest filtration efficiency numbers for any face masks in the market,” stated Kronos. “All test method acceptance criteria were met. Testing was performed in compliance with U.S. FDA good manufacturing practice (‘GMP’) regulations 21 CFR Parts 210, 211, and 820.” The need for high-quality masks continues, even as the COVID-19 pandemic appears to be easing in the United States. Some parts of the world are seeing spikes in numbers, and experts predict that the threat of COVID-19 is far from over. “Many health experts say the loosening of COVID restrictions is probably due to rising COVID fatigue, in which people are tired of mandates, lockdowns, and anxiety-inducing daily case and death numbers,” a recent “Fortune” article states. The article quoted Tedros Adhanom Ghebreyesus, director general of the World Health Organization (“WHO”): “In some countries, high vaccine coverage, combined with the lower severity of omicron, is driving a false narrative that the pandemic is over. . . . At the same time, low vaccine coverage and low testing rates in other countries are creating the ideal conditions for new variants to emerge.” The “Fortune” article noted the consensus among experts that new COVID variants will soon emerge that may or may not be more virulent; the delta and omicron variants are examples of variants that have already been identified. “The WHO has warned the next COVID variant will be more infectious than omicron, and it may be more deadly,” the article states. Kronos is focused on next-generation wellness consumer-electronics products and PPE solutions. Originally founded in 2002 and funded by the U.S. military to develop electrostatic air movers, the company has since evolved into the consumer air-purification space, initially focusing on developing, marketing and selling its proprietary air movement and purification technology. Its proprietary technology is now also being implemented in multiple standalone products for businesses, homes and vehicles of all types to move, sterilize and filter air. The company is exploring broad ranges of additional markets for standalone and embedded Kronos CORE technology-based devices, including schools, universities, healthcare facilities, operating rooms, manufacturing clean rooms, and automobiles and commercial aircraft cabins. For more information, visit the company’s website at www.KronosATI.co. NOTE TO INVESTORS: The latest news and updates relating to KNOS are available in the company’s newsroom at https://ibn.fm/KNOS

• Eat Well Investment Group Inc. is an investor and rapidly growing producer of nutritious plant-based foods
• Eat Well recently announced that its Belle Pulses subsidiary is increasing its legumes-based protein output capacity in response to global concerns about the food supply chain in the wake of the COVID pandemic and Russia’s war on Ukraine
• Russia and Ukraine are some of the world’s largest exporters of peas, as well as other consumer products whose commerce is threatened by the war’s devastation as well as the international community’s economic sanctions on Russia
• Another Eat Well subsidiary, Amara Organic Foods, recently announced it is increasing its baby food brand distribution through agreements with Sobeys and IGA national retail stores

The rising price of gasoline has drawn a great deal of attention from consumers as world events prompt inflation in key lifestyle sectors (https://ibn.fm/Inlqk), but disruptions to the global food supply chain as a result of these events have the potential to inflict a much greater harm on consumers’ lifestyles. Companies like Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) are taking an aggressive approach toward dealing with food supply chain concerns that have arisen in the wake of the COVID-19 pandemic’s years-long battering on global economies, followed by the devastation of a region known as the world’s breadbasket during Russia’s ongoing war against Ukraine (https://ibn.fm/2AF6a). The economic sanctions imposed on Russia’s international commerce as a result of the war has further hampered the global supply of products used in agricultural labor, as well as the fruits of agriculture that so many people are used to enjoying (https://ibn.fm/OUmxk). Eat Well Investment Group is stepping up its production of pulse-sourced protein (proteins from plants in a variety of legume families) to help meet the sudden demand for foods that can no longer be obtained from Russia and Ukraine. The company reported April 1 that it produced 90,000 metric tons (tonnes) of proteins from legumes such as peas, chickpeas, lentils and beans during 2021, and is taking steps to increase annual protein production capacity to nearly 100,000 metric tons at its subsidiary Belle Pulses’ flagship plant in Saskatchewan while also increasing annual production at a plant in the United States to 15,000 tonnes. It’s a fraction of the 1 million tonnes of peas Russia exports annually as well as the approximately 500,000 tonnes of peas exported by Ukraine each year. “It has always been our investment thesis that the globe will shift to more sustainable and environmentally friendly proteins. The next 24 months will be crucial for international food security as one of the world’s largest producers of fertilizer, agricultural crops and pulses is effectively closed off from the rest of the world,” Eat Well Group CEO and Director Marc Aneed stated (https://ibn.fm/e9XLX). “Belle is receiving increased recognition from international customers looking to secure quality, safe and reliable proteins at scale,” Eat Well Group Chief Investment Officer Mark Coles added. “Belle has emerged as a pivotal player in global pulse protein production and continues to draw significant interest in its products.” Belle Pulses is 100 percent owned by Eat Well Group and supplies customers in over 35 countries with its products. Another of Eat Well’s subsidiaries, Amara Organic Foods, has also increased the availability of its fast-growing baby food brands — adding distribution through select stores under the Sobeys and IGA national retail chains across Canada. “Sobeys and IGA stores (are) some of North America’s most well-known and established grocery retailers,” Aneed stated in the company’s news release (https://ibn.fm/4dyeX). “The demand for plant-based infant nutrition continues to be strong as we accelerate growth across Eat Well Group’s CPG sector. We congratulate the Amara team for ongoing success.” For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

In addition to high-profile speakers such as Facebook’s former head of advertising, the editor-in-chief of Forbes and many others, Noble Capital Markets just announced two more notable individuals that will be part of NobleCon18’s agenda next month at The Guitar Hotel near Miami. Brig. Gen. Holt, the Deputy United States Military Representative to the North Atlantic Treaty Organization (“NATO”), supports the Military Representative and the Chairman of the Joint Chiefs of Staff in executing the U.S. political-military mission at the North Atlantic Council. The general is a command pilot with more than 3,900 flying hours in a variety of aircraft. His dissertation was awarded a “with distinction” honor at the Royal Superior College of Defense in Brussels. Additionally, he has published a variety of papers across a range of national security issues and is a life member of the Wings Club and the Council on Foreign Relations. The general is uniquely qualified to opine on the Russian invasion of Ukraine. Chris Ruddy, CEO of Newsmax, founded Newsmax in 1998 to publish online and offline content in the fields of news, politics, health and finance. Newsmax.com ranks consistently as one of the country’s most trafficked news websites. Newsmax TV, a cable and over-the-top media service news channel started in 2014, is carried in more than 70 million U.S. homes. Additionally, Ruddy sits on the Board of Directors of the Financial Publishers Association, the industry organization representing investment publications that reach 25 million Americans monthly. A Newsweek cover story named him as one of America’s top 20 most influential news media personalities. Admission to NobleCon is free for all levels of investors from self-directed novices to institutional investors, thanks to Noble, Channelchek, Sponsors and The Presenting Companies. Attendance is limited to 1,000. To secure a ticket for the April 20-21 investor conference, visit https://nobleconference.com/register/investor-guest Full list of speakers: https://channelchek.com/news-channel/Scheduled_Speakers_NobleCon18 The presenting companies: https://channelchek.com/news-channel/NobleCon18_Presenting_Companies

• Knightscope’s spring Robot Roadshow is set to kick off on April 12, and will cover key states in the U.S. before making it to the capital for National Police Week
• Knightscope plans to leverage the roadshow to forge direct connections with potential clients and strike up conversations in a compelling fashion
• The roadshow will cover as many major cities as possible for the 2022 calendar year

Studies have shown that 70% of individuals are converted into repeat paying clients once they attend an experiential marketing event. In addition, 85% of clients note that they are more likely to make a purchase after participating in such events (https://ibn.fm/K2rQL). Knightscope (NASDAQ: KSCP) is a leader in developing autonomous security technologies for the U.S. market. As such, it has announced its spring schedule for the Robot Roadshow, intending to grab potential clients’ attention, forge direct connections with them, and strike up conversations that would aid in pushing its technology and business forward (https://ibn.fm/knaLm). Dubbed “The Robot Roadshow,” this periodic event allows attendees to get a feel and more in-depth understanding of the technology that enables their autonomous security Robots (“ASRs”) to make sites safer today. Attendees interact directly with each robot and see the Knightscope Security Operations Center (“KSOC”) user interface in action. The company has three primary offerings: the K1 stationary machine, the K3 indoor machine, and the K5 outdoor machine. These ASRs autonomously patrol client sites with no remote control, offering a visible, force-multiplying, physical security presence that offers additional asset protection, crime deterrence, and monitoring changes. The crime-fighting robots tour will feature these three ASR models and will be hosted virtually by a Knightscope expert. The roadshow has, so far, made 35 landings in 10 different states, and the spring line-up will kick off on April 12, 2022, in the Midwest. The tour is currently scheduled to hit Minnesota, Illinois, Wisconsin, Ohio, and Indiana, before making its way to Washington, just in time to celebrate National Police Week. The plan for the Robot Roadshow is to cover as many major cities as possible for the 2022 calendar year. Knightscope is confident that with these roadshows, it will attract new clients and retain existing ones, ultimately creating value for its shareholders. You can view a video of a previous Robot Roadshow hosted by the Los Angeles Police Department at https://ibn.fm/J5H44 For more information about Knightscope (NASDAQ: KSCP), visit the company’s website at www.Knightscope.com, and if you have a need for subscription service you may request a private demonstration of the technology at www.Knightscope.com/demo. NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

• Cepton continues to be at forefront of state-of-the-art engineering science; sponsors The AutoDrive Challenge(TM) II and serves as an exclusive LiDAR supplier
• During this competition, faculty members and students from ten North American universities will spend four years developing autonomous vehicles that require no human interaction in their operations
• Participating teams will work with directional lidars for the first time as academic community recognizes Cepton lidars for their exceptional combination of performance, reliability, and embeddability

As a leading innovator in the LiDAR space, Cepton (NASDAQ: CPTN) has always been committed to becoming the bridge between cutting-edge science and the automotive industry. Autonomous driving and its great enabler – LiDAR technology – are ready to take over mobility space, as the innovative technology makes strides in terms of decreasing costs and improving commercialization potential. Cepton appears determined to be a visible part of that landscape, as it becomes a sponsor and an exclusive LiDAR provider for ten universities in North America gathered in a four-year STEM education program called The AutoDrive Challenge(TM) II (https://ibn.fm/283iq). A result of the partnership between GM and SAE, The AutoDrive Challenge(TM) is designed to advance STEM education and contribute to the ground-breaking work within the autonomous driving space. Participating academic institutions include Kettering University, Michigan Technological University, North Carolina A&T State University, Pennsylvania State University-University Park, Queen’s University, Texas A&M University, The Ohio State University, University of Toronto, University of Wisconsin-Madison, and Virginia Polytechnic Institute and State University. During the program, faculty members and students will develop autonomous vehicles that can navigate urban driving courses following SAE’s Level 4 of driving automation, which means that vehicles do not require human interaction in their operations. The vehicles will be tested in Mcity, the world’s first purpose-built ground for testing the performance and safety of automated vehicles, which is used by many leading automotive OEMs trial smart mobility projects. To achieve a high level of security, participating teams will need to equip their vehicles with advanced perception capabilities, for which LiDAR technology is expected to play a critical role. This is where Cepton steps in. The Company will provide high-performance LiDAR solutions to the teams to enable their integrated systems. The AutoDrive Challenge(TM) II proves that LiDAR is becoming increasingly present in the autonomous driving space. “We felt this program offered us a fantastic opportunity to help advance the LiDAR education in both the automotive industry and academia,” said Dr. Jun Pei, CEO of Cepton. “LiDAR is going mainstream with it being deployed in advanced driver assistance systems (‘ADAS’) in everyday consumer vehicles to be available in the next few years. This sensor technology is not only capable of improving vehicle safety but also critical in enabling higher levels of autonomy. We are dedicated to helping proliferate the benefits of LiDAR technology by focusing on increasing its mass-market scalability with our proprietary Micro Motion Technology (MMT(R)), which is designed to enable an optimal balance between performance, reliability, and affordability. While we look forward to working with all the participants to help enhance their AV projects with LiDAR perception, we are also excited to learn from the experience working with such an intellectual community,” he concluded. The future for self-driving vehicles and their enabling technologies such as LiDAR systems seem bright. With improved safety levels of autonomous vehicles, the number of human drivers is expected to decrease gradually. Some projections go as far as to predict that human driving is on its way to soon becoming the thing of the past. IDTechEx, a market research firm focused on emerging technologies, believes that the safety level of autonomous vehicles will reach or even surpass that of human drivers in 2024, leading to a potential ban of human drivers on public roads by 2050 (https://ibn.fm/QH8Dn). Although this may be a bold prediction, the world appears to be on the brink of a new era in autonomous driving – and LiDAR technology has an opportunity to become a big part of that disruption. This innovative technology has been catching up to optical cameras – its main competing technology – and will take over if the advancements in optical cameras fail to measure up. For more information, visit the company’s website at www.Cepton.com. NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

• Chase Edgelow and the EverGen Infrastructure team has sought to cater to the rapidly rising demand for carbon-free energy sources through a focus on renewable natural gas (“RNG”)
• Current forecasts suggest that as much as 10% of North America’s natural gas demand could be satisfied by RNG in the coming future
• EverGen is planning to expand their production footprint, recently signing a letter of intent to acquire a stake in an agricultural project in Alberta wherein biodegradable waste will be converted into RNG and sold to FortisBC
• RNG proponents increasingly believe that the fuel source could eventually play a role in targeting two of society’s most pressing issues – the world’s growing waste production as well as its mission to achieve a carbon neutral future

The world produces over 2.12 billion tons of waste per annum; To put that figure into perspective, if all the waste was put on trucks, it would circle around the world 24 times (https://ibn.fm/UJnsY). For Chase Edgelow, that is an opportunity. The CEO and Founder of British Columbia-based EverGen Infrastructure (TSX.V: EVGN) (OTCQB: EVGIF) is creating a cutting edge renewable energy company, focused around converting organic waste into renewable natural gas (“RNG”), a non-fossil fuel form of natural gas. With governments the world over pledging to pursue a carbon neutral future in the coming years, RNG stands to play a significant role in the decarbonization of North America’s gas supply going forward. Forecasts suggest that as much as 10% of the continent’s natural gas demand could be satisfied by RNG in the not-too-distant future. Nowhere is that phenomenon more evident than within the utilities sector. Canada’s Enbridge Gas Inc, North America’s largest natural gas utility by volume, has already begun to work towards this goal, recently announcing a partnership to design and build eight new RNG project sites across the United States (https://ibn.fm/z7qeZ) and construct seven large-scale Canadian RNG projects with an additional 50+ projects in various stages of development; all whilst simultaneously breaking ground on what is soon set to be Ontario’s largest RNG facility by Niagara Falls (https://ibn.fm/hd2iE). EverGen Infrastructure Corp caters to the burgeoning RNG market, most recently through the signing of a letter of intent for the acquisition of a 67% interest in a biogas facility in Alberta. The facility, which will be centred around the currently operating Perry Family Farm, will seek to convert biodegradable agricultural waste into biogas which will subsequently be upgraded to RNG for use in the gas grid. The facility has an offtake agreement with FortisBC, with the supplied RNG contributing to FortisBC’s target to source at least 15% of its gas supply from carbon neutral sources by 2030 (https://ibn.fm/7g2fF). “We are thrilled to be partnering with GrowTEC and working with the Perry Family Farm on EverGen’s first project in the Alberta market. Alberta is a region with high quality organic feedstock and represents a strategic market for EverGen as it plans to become a dominant RNG producer in the province,” said Chase Edgelow, CEO of EverGen. EverGen manages two organic waste processing facilities in British Columbia in addition to Fraser Valley Biogas, Western Canada’s first RNG facility which has been in production since 2011. The Net Zero Waste compost facility in Abbotsford will be expanding this year with construction of an Anaerobic Digester facility that will use blended feedstock from agricultural, municipal, and commercial organic waste to produce RNG that will feed into FortisBC’s gas network under a long-term contract. The Sea to Sky Soils facility near Pemberton, BC plans to grow its waste processing capacity by approximately 50% and has future RNG potential as well. The company has plans to further its geographic footprint, and is evaluating several RNG projects in Alberta, Ontario, and Quebec. Organic waste derived from food production, food waste, farming, landfill, and wastewater treatment are said to be responsible for up to 25 percent of human-caused global emissions of methane, a harmful greenhouse gas. Chase Edgelow and other RNG advocates the world over believe that they can, rather uniquely, address two critical issues through the production of renewable natural gas, namely – how to tackle the world’s increasing waste production whilst simultaneously, targeting cleaner, renewable energy sources (https://ibn.fm/6PCtJ). “We need to deal with our waste, as humans,” [Edgelow] stated. “We need waste infrastructure. But we also want to decrease carbon emissions. So why would we let the energy from that waste infrastructure go straight into the atmosphere and go to waste?” For more information about EverGen Infrastructure Corp. and its projects, visit the company’s website at www.EvergenInfra.com. NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

• Hollywall Entertainment Inc. currently has a market cap of $73.53 million, attributed mainly to its leveraging of developing technologies
• The company, through HW Vision, a wholly-owned subsidiary, is pushing 5G and banking on its adoption over the coming years, projected to drive a 52% growth in the 5G services market by 2030
• Hollywall is also exploring new ways to create digital equity as it seeks to address the digital divide
• Through its investment in 5G, Big Data, and AI, Hollywall is not only growing its digital marketplace presence but also driving value for its shareholders

Hollywall Entertainment (OTC: HWAL) has positioned itself as a telecommunication, media, infrastructure, technology, broadcasting, and entertainment company. Through its budding list of subsidiaries, the company has achieved a market cap of $73.53 million as of March 2022. For a company founded in 2009, its growth has been incredible and has been primarily attributed to its identification and capturing of high-growth technologies (https://ibn.fm/v7PkQ). Hollywall is focused on the potential of the digital marketplace, pushing its investment in this sector. Through its wholly-owned subsidiary, HW Vision, the company offers state-of-the-art services, tapping into industries such as video broadcasting, managed internet services, domain hosting, telehealth services, and, most importantly, 5G and fiber network installation services. In 2021, the 5G services market size was valued at $47.3 billion. Furthermore, it is projected that by 2030, this sector will post a CAGR of 52% over the forecast period (2022-2030), driven mainly by the growing demand for high-speed data connectivity for unified Internet of Things (“IoT”) applications (https://ibn.fm/IHmb4). The North American market is projected to post the highest growth in 5G adoption over this period, mainly stemming from the proliferation of the internet, along with 5G’s potential to help realize transformation in various industry verticals. Hollywall is confident that the 5G sector alone has the potential to generate significant interest and market opportunities for the company going forward. Its management also reckons that this industry’s growth will be further complemented by the company’s community-focused initiatives, including but not limited to the development of smart cities. Even as the company explores other new avenues of revenue and value creation for its shareholders, it continues to bank on 5G technology as one of the key pillars that will define its growth as time progresses. Recently, the company announced its venture into music NFTs with the formation of a new research and development (“R&D”) division that would also explore cryptocurrency technologies, blockchain, and token omics (https://ibn.fm/pLVmA). Hollywall is also exploring new ways and methods of creating digital equity to address the so-called digital divide between the quality internet haves and have-nots. This has seen the launch of its “Fiber to the People” program, a campaign that acknowledges how the digital divide disproportionately affects the elderly, those living in rural areas and in poverty, as well as the homeless. Its management believes that 5G will be integral to solving this problem and improving society overall (https://ibn.fm/y9DTo). Hollywall is no stranger to pushing the envelope, sparking conversations, and innovating, particularly when it comes to technology and offering access to the internet. With its growing portfolio of products and service offerings, the company proves that 5G, Big Data, and Artificial Intelligence (“AI”) are the future. For more information, visit the company’s website at www.Hollywall.com. NOTE TO INVESTORS: The latest news and updates relating to HWAL are available in the company’s newsroom at https://ibn.fm/HWAL